Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Random-start corifollitropin alpha plus oral progestin protocol in oocyte donors
2018-003106-29Phase 3Completed
- Sponsor
- Centre Hospitalier Intercommunal de Créteil
- Start
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of corifollitropin alfa and desogestrel in infertility, sponsored by Centre Hospitalier Intercommunal de Créteil. Primary endpoint: Number of oocytes retrieved. Started Sep 2018; status: completed.
02
Drugs
corifollitropin alfadesogestrel
03
Conditions
infertility
Beyond the preview
Go deeper on 2018-003106-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003106-29.